Longevity & Aging · Gut & Microbiome
Bacteroides ovatus (and its metabolite lysophosphatidylcholine) is depleted in Alzheimer's and supplementation reduces amyloid and rescues cognition in Alzheimer's mouse models
In plain terms: Does restoring the gut bacterium Bacteroides ovatus reduce Alzheimer's pathology (shown in mice)?
Part of: • Aging
A single 2025 Cell Metabolism study showed supplementing B. ovatus (or its LPC metabolite) cut amyloid and improved cognition in 5xFAD mice via GPR119/anti-ferroptosis; independent FMT and gut-microbiota work supports a real gut-to-Alzheimer's axis at the genus level, which nudges this to weak support — but no independent group has tested B. ovatus itself against AD endpoints, and one study even found Bacteroides worsening amyloid, so it stays preliminary.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
<!-- vault-context --> Norwitz affirms this claim. Consensus below reflects independent literature only.
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Chen 2022 · Gut | animal | mixed | moderate | Gut dysbiosis drove PUFA-associated neuroinflammation and AD pathology in mice; supports a causal gut-AD axis but does not identify B. ovatus as protective. |
| 2024 venue: Curr Alzheimer Res · Curr Alzheimer Res | observational | mixed | low | Gut-microbiota disruptions associate with preclinical AD cognitive deficit; supports microbiome-AD link broadly, no B. ovatus-specific rescue. |
| Zha 2025 · Cell Metab | animal | supports | moderate | Cited paper verified: Bacteroides depleted/Clostridium raised in 5xFAD; B. ovatus or LPC reduces Abeta & rescues cognition via GPR119->ACSL4->suppressed ferroptosis; AD human fecal/serum B.ovatus & LPC low. Mechanism is GPR119/ferroptosis, NOT MFSD2A/NRF2. |
| Dissanayaka DMS et al] # corrected 2026-08-17 from PubMed; was [2025 venue: Biomolecules · Biomolecules | observational | tested-null | low | Gut microbial composition/SCFA in cognitively unimpaired adults; general microbiome-cognition context only, not B. ovatus rescue. |
| Cox 2019 · Scientific Reports | animal | contradicts | moderate | In Tg2576 AD mice, age-related Bacteroides expansion tracked Abeta and gnotobiotic Bacteroides colonization exacerbated Abeta deposition, opposing the \"Bacteroides is protective\" direction. |
| Sun 2019 · Translational Psychiatry | animal | mixed | low | FMT in APP/PS1 mice reduced Abeta deposition and tau phosphorylation and restored SCFAs/cognition (not B. ovatus-specific). |
| Kim 2020 · Gut | animal | supports | moderate | Transfer of healthy microbiota into ADLPAPT AD mice reduced amyloid and tau pathology and reversed dysbiosis (genus-level, not B. ovatus-specific). |
| Liu 2020 · Food Funct | animal | mixed | low | Fermented milk raised Bacteroides/Faecalibacterium abundance and reduced Abeta in APP/PS1 mice; correlational and whole-food confounded. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.